本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Werewolf Therapeutics, Inc.

0.6983
-0.0943-11.90%
盤後0.73320.0349+5.00%19:55 EDT
成交量:34.99萬
成交額:25.64萬
市值:3,130.28萬
市盈率:-0.43
高:0.8201
開:0.7811
低:0.6951
收:0.7926
資料載入中...
2025/03/11

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/03/11

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/03/11

重要事件披露

Form 8-K - Current report
2025/02/24

重要事件披露

Form 8-K - Current report
2024/11/15

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/12

重要事件披露

Form 8-K - Current report
2024/11/12

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/07

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/11/07

重要事件披露

Form 8-K - Current report
2024/08/08

員工持股計劃

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2024/08/08

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/08/08

重要事件披露

Form 8-K - Current report
2024/06/25

重要事件披露

Form 8-K - Current report
2024/06/03

重要事件披露

Form 8-K - Current report
2024/05/28

重要事件披露

Form 8-K - Current report
2024/05/07

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/05/03

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/03

重要事件披露

Form 8-K - Current report